5 days a week versus 6 days a week fractionated Radiotherapy in Cervical Carcinoma
Phase 3
- Conditions
- Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecified
- Registration Number
- CTRI/2023/06/054226
- Lead Sponsor
- Prof Dr Sunil Choudhary
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
18- to 65- year-old females with histologically proven carcinoma cervix stage IB3 to IVA
Exclusion Criteria
Patients previously treated for any pelvic malignancy, lactating and pregnant females
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ocal control, Disease Free survival & Overall survivalTimepoint: 5 years
- Secondary Outcome Measures
Name Time Method ilTimepoint: Nil